The Arab Drug Company announced earnings results for the full year ended June 30, 2021. For the full year, the company announced total revenue was EGP 537.046 million compared to EGP 521.072 million a year ago. Net income was EGP 102.039 million compared to EGP 92.799 million a year ago. Basic earnings per share from continuing operations was EGP 13.73 compared to EGP 12.5 a year ago.